LOGISTIC DISCRIMINANT-ANALYSIS OF LIPIDS AND APOLIPOPROTEINS IN A POPULATION OF CORONARY-BYPASS PATIENTS AND THE SIGNIFICANCE OF APOLIPOPROTEIN-C-III AND APOLIPOPROTEIN-E

被引:62
作者
CHIVOT, L
MAINARD, F
BIGOT, E
BARD, JM
AUGET, JL
MADEC, Y
FRUCHART, JC
机构
[1] FAC PHARM NANTES,BIOCHIM PHARMACEUT LAB,1 RUE GASTON VEIL,F-44035 NANTES,FRANCE
[2] INST PASTEUR,SERLIA,LILLE,FRANCE
[3] FAC PHARM NANTES,BIOMATH & BIOSTAT LAB,NANTES,FRANCE
[4] CHU NANTES,HOP GUILLAUME & RENE LAENNEC,BIOCHIM LAB B,NANTES,FRANCE
关键词
Apolipoproteins A-I; B; C-III; E; Coronary bypass; Lipids; Logistic discriminant analysis;
D O I
10.1016/0021-9150(90)90042-H
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
The lipid and apolipoprotein states of 74 men (mean age 49.96 ± 5.9 years) were studied 24 h before coronary bypass surgery and their results were compared with those of a control group of 78 men (mean age 48.88 ± 5.41 years). Apolipoproteins C-III (apo C-III) and E (apo E) were determined in particles with (LpB) and without (nonLpB) apo B separated using a concanavalin A reagent. Apo C-111 was significantly increased in LpB particles (P < 0.001), and apo E in LpB (P < 0.001) and nonLpB (P < 0.001) particles. The significant variables selected in logistic discriminant stepwise analysis were total cholesterol/HDLcholesterol, apo E-nonLpB and apo C-III-LpB. This last parameter, which is more discriminant than triglycerides, provides a more specific indication of dyslipoproteinemia in coronary bypass patients; in association with the other two variables, it significantly improved the percentage of correctly classified individuals. © 1990.
引用
收藏
页码:205 / 211
页数:7
相关论文
共 23 条
[1]  
[Anonymous], 1984, MULTIVARIATE DESCRIP
[2]   PROGRESSION AND REGRESSION OF HUMAN CORONARY ATHEROSCLEROSIS - THE ROLE OF LIPOPROTEINS, LIPASES AND THYROID-HORMONES IN CORONARY LESION GROWTH [J].
BARTH, JD ;
JANSEN, H ;
KROMHOUT, D ;
REIBER, JHC ;
BIRKENHAGER, JC ;
ARNTZENIUS, AC .
ATHEROSCLEROSIS, 1987, 68 (1-2) :51-58
[3]  
BERGLUND G, 1981, LANCET, V1, P744
[4]   EPIDEMIOLOGY OF CORONARY HEART-DISEASE - THE FRAMINGHAM-STUDY [J].
CASTELLI, WP .
AMERICAN JOURNAL OF MEDICINE, 1984, 76 (2A) :4-12
[5]  
Cox D.R., 1989, ANAL BINARY DATA, V32
[6]  
FOX MH, 1987, J THORAC CARDIOV SUR, V93, P56
[7]  
FRIEDEWALD WT, 1972, CLIN CHEM, V18, P499
[8]  
FRUCHART JC, 1985, METHOD ENZYMAT AN, P126
[9]   APOLIPOPROTEIN-B METABOLISM IN SUBJECTS WITH DEFICIENCY OF APOLIPOPROTEINS-CIII AND APOLIPOPROTEIN-A-I - EVIDENCE THAT APOLIPOPROTEIN-CIII INHIBITS CATABOLISM OF TRIGLYCERIDE-RICH LIPOPROTEINS BY LIPOPROTEIN-LIPASE INVIVO [J].
GINSBERG, HN ;
LE, NA ;
GOLDBERG, IJ ;
GIBSON, JC ;
RUBINSTEIN, A ;
WANGIVERSON, P ;
NORUM, R ;
BROWN, WV .
JOURNAL OF CLINICAL INVESTIGATION, 1986, 78 (05) :1287-1295
[10]   CHANGES IN CHOLESTEROL AND TRIGLYCERIDE AS PREDICTORS OF ISCHEMIC-HEART-DISEASE IN MEN [J].
GLYNN, RJ ;
ROSNER, B ;
SILBERT, JE .
CIRCULATION, 1982, 66 (04) :724-731